Design and In Vitro evaluation of a novel vaginal drug delivery system based on gelucire

Current Drug Delivery

Volumn 6, Issue 2, 2009, Pages 159-165

  Madhavlal, Patel Geeta ^a   Manordas, Patel Madhabhai ^b  

^a GANPAT UNIVERSITY   (India)

^b Kalol Institute of Pharmacy   (India)

Author keywords

Gelucires; Mucoadhesion; Polyox polymers; Vaginal drug delivery

Indexed keywords

CARBAMAZEPINE; GELUCIRE; PROPOLIS;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULARY; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; PRIORITY JOURNAL; SHELF LIFE; SUPPOSITORY; VAGINA PESSARY;

ADHESIVENESS; ADMINISTRATION, INTRAVAGINAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CARBAMAZEPINE; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; FATS; FEMALE; MICROSCOPY, ELECTRON, SCANNING; MUCOUS MEMBRANE; OILS; PESSARIES; POLYETHYLENE GLYCOLS; POVIDONE; RABBITS; SILICON DIOXIDE; SURFACE PROPERTIES; WAXES;

EID: 66749105191     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109787846234     Document Type: Article

References (23)

1. Galal, S.E.L.; Massik, M. A.; Abdallah, O. Y.; Daabis, N. A. A Study of in-vitro release characteristics of carbamazepine extended release semi-solid matrix filled capsules based on gelucires. Drug Dev. Ind. Pharm., 2004, 30(8), 817-9.
2. Giunchedi, P.; Conte. U.La.; Manna. A Carbamazepine modified release dosage forms. Drug Dev. Ind. Pharm., 1991, 17, 1753-64.
3. Larkin, J. G.; Meellelan, A.; Munday, A.; Sutherland, M.; Bulter, E.; Brodie, M. J. A double blind comparison of conventional and controlled release formulations of carbamazepine in healthy subjects. Br. J. Clin. Pharm., 1989, 27, 313-22.
4. Gavini, E.; Hegge, A.B.; Rassu, G.; Sanna, V.; Testa, C.; Pirisino, G.; Karlsen, J.; Giunchedi, P. Nasal administration of Carbamazepine using chitosan microspheres. In vitro/in vivo studies. Int. J. Pharm., 2006, 307 (1), 9-15.
5. Patel, D.M.; Patel, N.M.; Pandya, N.N.; Jogani, P.D. Gastro retentive drug delivery system of carbamazepine. formulation optimization using simplex lattice design. A Technical Note. AAPS PharmSci. Tech., 2007, 8(1), E1-E5.
6. Amal, El-K.; Mona, El-K. Thermally reversible in situ gelling carbamazepine liquid suppository. Drug Deliv., 2006, 13, 143-48.
7. Baykara, T.; Yuksel, N. The preparation of prolong action formulations in the form of semisolid matrix in to hard gelation capsule of oxprenolol. II Thixocap Method. Drug Dev. Ind. Pharm., 1992, 18, 233-43.
8. Lee, C.H.; Chien, Y.W. Development and evaluation of a mucoadhesive drug delivery system for dual-controlled delivery of non-oxynol-9. J. Control. Release, 1996, 39, 93-03.
9. Genc, L.; Oguzlar, C.; Guler. E. Studies in vaginal bioadhesive tablets of acyclovir. Pharmazie, 2000, 55, 297-99.
10. Richardson, JL.; Whetstone, J.; Fisher, AN. Gamma-scintigraphy as a novel method to study the distribution and retention of a bioadhesive vaginal delivery system in sheep. J. Control. Release, 1996, 42, 133-42.
11. Geraghty, PB.; Attwood, D., Collett, JH.; Sharma, H; Dandiker, Y. An investigation of the parameters influencing the bioadhesive properties of Myverol 18-99/water gels. Biomaterials, 1997, 18, 63-7.
12. Barnhart, B.; Pretorius, ES.; Stolpen, A.; Malamud, D. Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging. Fertil. Steril., 2001, 76, 189-95.
13. Wilbur, K.; Ensom, M.H. Pharmacokinetic drug interaction between oral contraceptives and second generation anticonvulsants. Clin. Pharmacokinet., 2000, 38, 355-65.
14. Ceschel, GC.; Maffei, P.; Borgia, SL.; Ronchi, C.; Rossi, S. Development of a mucoadhesive dosage form for vaginal administration. Drug Dev. Ind. Pharm., 2001, 27, 541-47.
15. Bodmeier, R.; Paeratakul, O.; Chen, H.; Zhang, W. Formulation of sustained release wax matrices within hard gelatin capsule in fluidized bed. Drug Dev. Ind. Pharm., 1990, 16, 1505-19.
16. Brossard, C.; Ratsimbazafy, V.; Lefort, D.; Ylouses, D. Modeling of theophyllin compound release from hard gelatin capsule containing Gelucire matrix granules. Drug Dev. Ind. Pharm., 1991, 17, 1262-77.
17. Ratsimbazafy, V.; Bourret, E.; Duclos, R.; Brossard, C. Rheological behavior of drug suspensiojn in Gelucire mixtures and proxyphylline release from matrix hard gelatin capsule. Eur. J. Pharm. Biopharm., 1999, 48, 247-52.
18. Basavraj, B.V.; Sindhu, Abraham; Deveswaran, R.; Bharat, S.; Madhavan, V. Mucoadhesive effects of Carbopol on drug release rate from double phased suppositories. Asian J. Pharm., 2007, 1 (1), 93-95.
19. Parodi, B.; Russao, E.; Caviglioli, G.; Caffagi, S.; Bignardi, G. Development and characterization of a buccoadhesive dosage form of oxycodon hydrochloride. Drug Dev. Ind. Pharm., 1996, 22, 445-50.
20. Amal, El-Kamel; Mogda, Sokar; Viviane, Naggar; Saffa, Al Gamal. Chitosan and Sodium alginate based bioadhesive vaginal tablets. AAPS Pharm Sci Tech, 2002, 4(4), 1-7.
21. Satananta, W.; Craig, D Q M.; Newton, J. M. Evaluation of the mechanism of the drug release from glyceride bases. J. Pharm. Pharmacol., 1995, 47, 182-87.
22. Peppas, N.A. Analysis of Fickian and non Fickian drug release from polymers. Acta Helv., 1985, 60, 110-11.
23. San-Vivente, A.; Harnandez, R.M. Gacon, M. B.; Pedraz, J. L. Effect of aging on the release of salbutamol sulphate from lipid matrices. Int. J. Pharm, 2000, 208, 13-21.